Jump to content

BLipkin

Members - Bounced Email
  • Posts

    16
  • Joined

  • Last visited

  • Days Won

    1
  • Country

    United States

Everything posted by BLipkin

  1. Cool ! I didn't even realize you could break them until I saw your post! I haven't been able to get all of them with one swipe either. Merry Christmas!
  2. At our institution, Pharmacy handles the factors, ATIII, and rFVIIa. The blood bank still has RhIG and albumin. As to the matter of cost, there are quite a few distributors for factors that will set up consignment programs where you only pay for the products used, and they are very good about rotating stock as expiration dates get short.
  3. The 14th Edition of the AABB Technical Manual has a "Determining Inventory Levels" section starting on page 80. There is no comparable section in the more recent (16th Ed.) Technical Manual.
  4. My understanding of aspirin vs Plavix is such: Aspirin disrupts the PLTs ability to adhere. If you can introduce non-aspirinated PLTs into circulation taht will adhere, the patient's aspirinated PLTs will then agrregate to them and form a plug. Thus is patients on aspirin who are bleeding, usually only one dose of platelets is sufficient to obtain hemostasis. Plavix affetcs both the PLTs aherence and aggregation. The tricky part is, is if there is still free Plavix in the patient's plasma, and if transfused PLTs then get exposed to it before they can adhere/aggregate then they will effectively be non-functional. Therefore you will usually need mulitple doses of platelets to acheieve hemostasis- and there is really no good way to know what that magic number will be.
  5. We used to run IS XM on our Provue using Buffered Gel Cards- we never had any regulatory issues. However, we stopped due to the fact that we can perform them (IS XM) faster and cheaper using tubes. The question I would pose to an inspector is what exactly meets the FDA Potency requirement in any immediate spin crossmatch?
  6. We have a Tissue Coordinator who is an OR nurse who's responsible for the ordering and recieveing and most of the documentation. OR stores all room temperature products, blood bank only stores frozen tissue/bone as we have a -75 C freezer. For these products only do we issue on a paper ledger to the OR when needed- otherwise they are the OR's responsiblity. It has worked out good for us, but we are fortunate to have a really capable person as the tissue coordinator.
  7. Hi all, I'm wondering what others view as "must have" reference books for blood bank. Looking to add to my collection, but want to make a good choice given the high cost. My most used books currently are: 1. Judd's Methods in Immunohematology (Judd) 2. Blood Group Antigens & Antibodies (Reid and Lomas-Francis) 3. AABB Technical Manual Currently thinking of getting Serologic Problem Solving or Rossi's Principles of Transfusion Medicine. Anyone have any thoughts or suggestions?
  8. If you have a copy of the 14th Edition AABB Technical Manual (the 50th Anniversary Edition), there are 3 methods described for determining inventory levels (starting on page 80). They are: average weekly use estimate, average daily use estimate, and moving average method.
  9. This was how we did things for over six years while we were without a blood bank system. We enetered the Type and Screen results into the LIS in order to not only generate reports, but also to generate charges to the billing system. We never had any major issues because of this. The key for us to always go to the paper patient/transfusion history when doing any testing/product selecting on a patient, and not to consult the results in the LIS.
  10. Hello out there, Is there anyone out there testing Eluates using Immucor's Capture-R products ? (Ready Screen, Ready ID, ect.) If so, would you mind sharing your SOP? I've done some initial experimenting, but have had mixed results. Thanks for your help, Brian
  11. Another possiblility, although with two incompatible units I think it would be a long shot, is that the donor cells themselves are DAT positive. We run into this once or twice a year, but usually only with a single unit at a time.
  12. Our policy (computer and downtime) requires that a visual inspection of any product be performed and found acceptable upon receipt of the product and at time of issue. Our Visual Inspection procedure for platelet products has platelete swirl as one of the main criteria- and in it's absence, those platelets should not be accepted into invenotry, or issued to a patient since the visual inspection at th\at point is considered to have failed.
  13. For those of you performing unit type confirmations on the ECHO, are you experiencing alot of probe clot detected errors? If you are not having clot detection issues, how are you processing/preparing the samples for testing. Thanks, Brian Lipkin MT(ASCP) Blood Bank Supervisor
  14. I don't see why that would be a problem. We routinely assign a tech to ABO/Rh, another to do screens, a third for phenotyping, and then have them each do an identification- if there is enough to go around. There has never been a problem with any of our inspectors (CAP, NYS, CMS). I think it is better to spread them out rather than overloading one individual- just my opinion.
  15. Hi all, During a recent CMS inspection it was suggested that in our Transfusion Reaction Policies, that we assign values to Hypotension and Hypertension where they are listed as symptoms of a possible transfusion reaction. Does anyone have values for these taht they are using? All of my sources simply state Hypotension and/or Hypertension. I guess another way to word it would be: how much of change in mmHg is considered significant in a transfusion recipient? Thanks for your help, Brian
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.